Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030

Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030

The global autoinjectors market is projected to to expand to a value of USD 3.02 billion in 2030 from USD 1.40 billion in 2024, with a significant CAGR of 13.6%. The autoinjector finished formulations market is projected to surge to a value of USD 134.27 billion in 2030 from USD 67.30 billion in 2024, growing at a CAGR of 12.2%.

Favorable reimbursement policies in North America and Europe coupled with launch of biosimilars across the globe are some of the factors contributing towards the market growth.

“The manual autoinjectors segment accounted for the largest share in 2023.”

On the basis of technology, the autoinjectors market is further segmented into manual, and automatic. The manual autoinjectors segment dominated the market in 2023, owing to the rise in demand due to rising incidence of conditions such as diabetes, multiple sclerosis, and rheumatoid arthritis. Furthermore, cost-effectiveness and expanding new therapeutic applications, is likely to increase their overall market potential for manual autoinjectors in coming years.

“By end user, the home care settings segment accounted for the largest share in the autoinjectors market.”

The end user segment in the autoinjectors market is segmented into home care settings, hospitals & clinics, and ambulatory care settings. In 2023, the home care settings segment accounted for the largest share owing to increased adoption of autoinjectors at home care settings. Furthermore, cost effectiveness, launch of user friendly autoinjector devices is likely to boost the growth of the home care settings segment. Use of autoinjectors for emergency situations such as anaphylactic reactions is likely to increase demand for autoinjectors in hospitals & clinics further propelling the growth of the market.

“North America: the largest share of the autoinjectors market”

North America dominated the autoinjectors market in 2023 and likely continue dominance during the forecast period. Well-developed healthcare infrastructure, prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis and favourable reimbursement policies in North America are some of the factors influencing the use of autoinjectors subsequently contributing towards market growth. The Asia Pacific autoinjectors market is predicted to grow at the significant CAGR during the forecast period of 2024-2030. The growth of the region is primarily attributed to the presence of large number of pharmaceutical and biopharmaceutical companies and growing number of regulatory apporvals for autoinjectors in the region especially China, India and South Korea.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%

By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%

By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

SHL Medical AG (Switzerland)

Ypsomed AG (Switzerland)

Becton, Dickinson and Company (BD) (US)

Recipharm AB (Sweden)

West Pharmaceutical Services, Inc.(US)

Phillips-Medisize (US)

Halozyme, Inc. (US)

Owen Mumford Ltd. (UK)

Abbvie Inc. (US)

Eli Lilly and Company (US)

Amgen Inc. (US)

Novo Nordisk A/S (Denmark)

Jonhson & Jonhson Services Inc. (US)

Sanofi (France)

GSK plc (UK)

Gerresheimer AG (Germany)

Haselmeier (Germany)

Oval Medical Technologies Ltd. (UK)

Kaleo, Inc. (US)

Solteam Incorporation Co., Ltd. (China)

Elcam Drug Delivery Devices (Israel)

Crossject (France)

Jabil, Inc. (US)

Congruence Medical Solutions LLC (US)

Midas Pharma GMBH (Germany)

Research Coverage:

This research report categorizes the autoinjectors market usage (reusable and disposable), technology (manual and automatic), route of administration (intramuscular and subcutaneous), therapy area (rheumatoid arthritis, multiple sclerosis, anaphylaxis, diabetes, obesity and other therapy areas), Volume (upto 3ml and above 3 ml) and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the autoinjectors market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the autoinjectors market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the autoinjector devices and finished formulations market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (rising prevalence of chronic diseases, increasing regulatory approvals for autoinjectors, high demand for biologics & biosimilars, growing adoption of self-administered medicines, government support and favorable reimbursement policies), restraints (Focus on needle-free drug delivery systems and prevalence of needle phobia ), opportunities (Impending patent expiry of biological molecules, launch of technologically-advanced autoinjectors) and Challenges (Development of autoinjectors for multiple drug viscosities) influencing the growth of the market.

Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the autoinjectors market.

Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the autoinjectors market

Competitive Assessment: SHL Medical AG (Switzerland), Ypsomed AG (Switzerland), Becton, Dickinson and Company (BD) (US), Abbvie Inc. (US), Eli Lilly and Company (US), Amgen Inc. (US), and Novo Nordisk A/S (Denmark) among others in the market.

Tables List

Table 1 Autoinjectors Market: Inclusions & Exclusions

Table 2 Impact Analysis Of Supply- And Demand-side Factors On Autoinjectors Market

Table 3 Recent Approvals Of Autoinjector Biologics In Us And Europe,

2020–2024

Table 4 Patent Expiry Of Key Biologics

Table 5 List Of Key Autoinjector Device Providers

Table 6 List Of Key Autoinjector Finished Formulation Product Providers

Table 7 List Of Key End Users

Table 8 List Of Key Regulatory Bodies

Table 9 North America: Regulatory Bodies, Government Agencies, And Other Organizations

Table 10 Europe: Regulatory Bodies, Government Agencies, And Other Organizations

Table 11 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations

Table 12 Rest Of The World: Regulatory Bodies, Government Agencies, And Other Organizations

Table 13 Autoinjectors Market: Porter’s Five Forces Analysis

Table 14 Import Data For Products (Including Autoinjectors),

2021–2023 (Usd Million)

Table 15 Export Data For Products (Including Autoinjectors),

2021–2023 (Usd Million)

Table 16 List Of Advantages And Disadvantages Of Autoinjector Technologies

Table 17 Number Of Patents Filed In Autoinjectors Market, 2014–2024

Table 18 Top 10 Patent Owners In Us In Autoinjectors Market, 2014–2024

Table 19 Detailed Analysis Of Key Patents In Autoinjectors Market, 2022–2024

Table 20 Indicative Pricing Of Finished Formulation Products,

By Key Player, 2023

Table 21 Indicative Pricing Analysis Of Therapy Areas For Autoinjector Finished Formulations, By Region, 2023

Table 22 Autoinjectors Market: Detailed List Of Key Conferences And Events, January 2024–december 2025

Table 23 Autoinjector Devices Market: Influence Of Key Stakeholders On Buying Process

Table 24 Autoinjector Finished Formulations Market: Influence Of

Key Stakeholders On Buying Process

Table 25 Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 26 Autoinjector Devices Market, By Usage, 2022–2030 (Million Units)

Table 27 Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 28 Disposable Autoinjector Devices Market, By Region,

2022–2030 (Usd Million)

Table 29 Disposable Autoinjector Devices Market, By Region,

2022–2030 (Million Units)

Table 30 North America: Disposable Autoinjector Devices Market, By Country, 2022–2030 (Usd Million)

Table 31 Europe: Disposable Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 32 Asia Pacific: Disposable Autoinjector Devices Market, By Country, 2022–2030 (Usd Million)

Table 33 Latin America: Disposable Autoinjector Devices Market, By Country, 2022–2030 (Usd Million)

Table 34 Middle East & Africa: Disposable Autoinjector Devices Market,

By Region, 2022–2030 (Usd Million)

Table 35 Disposable Autoinjector Finished Formulations Market, By Region, 2022–2030 (Usd Million)

Table 36 North America: Disposable Autoinjector Finished Formulations Market, By Country, 2022–2030 (Usd Million)

Table 37 Europe: Disposable Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 38 Asia Pacific: Disposable Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 39 Latin America: Disposable Autoinjector Finished Formulations Market, By Country, 2022–2030 (Usd Million)

Table 40 Middle East & Africa: Disposable Autoinjector Finished Formulations Market, By Region, 2022–2030 (Usd Million)

Table 41 Reusable Autoinjector Devices Market, By Region,

2022–2030 (Usd Million)

Table 42 Reusable Autoinjector Devices Market, By Region,

2022–2030 (Million Units)

Table 43 North America: Reusable Autoinjector Devices Market, By Country, 2022–2030 (Usd Million)

Table 44 Europe: Reusable Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 45 Asia Pacific: Reusable Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 46 Latin America: Reusable Autoinjector Devices Market, By Country, 2022–2030 (Usd Million)

Table 47 Middle East & Africa: Reusable Autoinjector Devices Market, By Region, 2022–2030 (Usd Million)

Table 48 Reusable Autoinjector Finished Formulations Market, By Region,

2022–2030 (Usd Million)

Table 49 North America: Reusable Autoinjector Finished Formulations Market, By Country, 2022–2030 (Usd Million)

Table 50 Europe: Reusable Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 51 Asia Pacific: Reusable Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 52 Latin America: Reusable Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 53 Middle East & Africa: Reusable Autoinjector Finished Formulations Market, By Region, 2022–2030 (Usd Million)

Table 54 Autoinjector Devices Market, By Technology, 2022–2030 (Usd Million)

Table 55 Autoinjector Devices Market, By Technology, 2022–2030 (Million Units)

Table 56 Autoinjector Finished Formulations Market, By Technology,

2022–2030 (Usd Million)

Table 57 Manual Autoinjector Devices Market, By Region,

2022–2030 (Usd Million)

Table 58 Manual Autoinjector Devices Market, By Region,

2022–2030 (Million Units)

Table 59 North America: Manual Autoinjector Devices Market, By Country, 2022–2030 (Usd Million)

Table 60 Europe: Manual Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 61 Asia Pacific: Manual Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 62 Latin America: Manual Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 63 Middle East & Africa: Manual Autoinjector Devices Market, By Region, 2022–2030 (Usd Million)

Table 64 Manual Autoinjector Finished Formulations Market, By Region,

2022–2030 (Usd Million)

Table 65 North America: Manual Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 66 Europe: Manual Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 67 Asia Pacific: Manual Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 68 Latin America: Manual Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 69 Middle East & Africa: Manual Autoinjector Finished Formulations Market, By Region, 2022–2030 (Usd Million)

Table 70 Automatic Autoinjector Devices Market, By Region, 2022–2030 (Usd Million)

Table 71 Automatic Autoinjector Devices Market, By Region,

2022–2030 (Million Units)

Table 72 North America: Automatic Autoinjector Devices Market, By Country, 2022–2030 (Usd Million)

Table 73 Europe: Automatic Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 74 Asia Pacific: Automatic Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 75 Latin America: Automatic Autoinjector Devices Market, By Country, 2022–2030 (Usd Million)

Table 76 Middle East & Africa: Automatic Autoinjector Devices Market,

By Region, 2022–2030 (Usd Million)

Table 77 Automatic Autoinjector Finished Formulations Market, By Region, 2022–2030 (Usd Million)

Table 78 North America: Automatic Autoinjector Finished Formulations Market, By Country, 2022–2030 (Usd Million)

Table 79 Europe: Automatic Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 80 Asia Pacific: Automatic Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 81 Latin America: Automatic Autoinjector Finished Formulations Market, By Country, 2022–2030 (Usd Million)

Table 82 Middle East & Africa: Automatic Autoinjector Finished Formulations Market, By Region, 2022–2030 (Usd Million)

Table 83 Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 84 Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Million Units)

Table 85 Autoinjector Devices Market For Subcutaneous Route Of Administration, By Region, 2022–2030 (Usd Million)

Table 86 Autoinjector Devices Market For Subcutaneous Route Of Administration, By Region, 2022–2030 (Million Units)

Table 87 North America: Autoinjector Devices Market For Subcutaneous Route Of Administration, By Country, 2022–2030 (Usd Million)

Table 88 Europe: Autoinjector Devices Market For Subcutaneous Route Of Administration, By Country, 2022–2030 (Usd Million)

Table 89 Asia Pacific: Autoinjector Devices Market For Subcutaneous Route Of Administration, By Country, 2022–2030 (Usd Million)

Table 90 Latin America: Autoinjector Devices Market For Subcutaneous Route Of Administration, By Country, 2022–2030 (Usd Million)

Table 91 Middle East & Africa: Autoinjector Devices Market For Subcutaneous Route Of Administration, By Region, 2022–2030 (Usd Million)

Table 92 Autoinjector Devices Market For Intramuscular Route Of Administration, 2022–2030 (Usd Million)

Table 93 Autoinjector Devices Market For Intramuscular Route Of Administration, 2022–2030 (Million Units)

Table 94 North America: Autoinjector Devices Market For Intramuscular Route Of Administration, By Country, 2022–2030 (Usd Million)

Table 95 Europe: Autoinjector Devices Market For Intramuscular Route Of Administration, By Country, 2022–2030 (Usd Million)

Table 96 Asia Pacific: Autoinjector Devices Market For Intramuscular Route Of Administration, By Country, 2022–2030 (Usd Million)

Table 97 Latin America: Autoinjector Devices Market For Intramuscular Route Of Administration, By Country, 2022–2030 (Usd Million)

Table 98 Middle East & Africa: Autoinjector Devices Market For Intramuscular Route Of Administration, By Region, 2022–2030 (Usd Million)

Table 99 Autoinjector Devices Market, By Therapy Area, 2022–2030 (Usd Million)

Table 100 Autoinjector Devices Market, By Therapy Area,

2022–2030 (Million Units)

Table 101 Autoinjector Finished Formulations Market, By Therapy Area,

2022–2030 (Usd Million)

Table 102 Autoinjector Devices Market For Rheumatoid Arthritis, By Region, 2022–2030 (Usd Million)

Table 103 Autoinjector Devices Market For Rheumatoid Arthritis, By Region, 2022–2030 (Million Units)

Table 104 North America: Autoinjector Devices Market For Rheumatoid Arthritis, By Country, 2022–2030 (Usd Million)

Table 105 Europe: Autoinjector Devices Market For Rheumatoid Arthritis,

By Country, 2022–2030 (Usd Million)

Table 106 Asia Pacific: Autoinjector Devices Market For Rheumatoid Arthritis,

By Country, 2022–2030 (Usd Million)

Table 107 Latin America: Autoinjector Devices Market For Rheumatoid Arthritis, By Country, 2022–2030 (Usd Million)

Table 108 Middle East & Africa: Autoinjector Devices Market For Rheumatoid Arthritis, By Region, 2022–2030 (Usd Million)

Table 109 Autoinjector Finished Formulations Market For Rheumatoid Arthritis, By Region, 2022–2030 (Usd Million)

Table 110 North America: Autoinjector Finished Formulations Market For Rheumatoid Arthritis, By Country, 2022–2030 (Usd Million)

Table 111 Europe: Autoinjector Finished Formulations Market For Rheumatoid Arthritis, By Country, 2022–2030 (Usd Million)

Table 112 Asia Pacific: Autoinjector Finished Formulations Market For Rheumatoid Arthritis, By Country, 2022–2030 (Usd Million)

Table 113 Latin America: Autoinjector Finished Formulations Market For Rheumatoid Arthritis, By Country, 2022–2030 (Usd Million)

Table 114 Middle East & Africa: Autoinjector Finished Formulations Market For Rheumatoid Arthritis, By Region, 2022–2030 (Usd Million)

Table 115 Autoinjector Devices Market For Diabetes, By Region,

2022–2030 (Usd Million)

Table 116 Autoinjector Devices Market For Diabetes, By Region,

2022–2030 (Million Units)

Table 117 North America: Autoinjector Devices Market For Diabetes, By Country, 2022–2030 (Usd Million)

Table 118 Europe: Autoinjector Devices Market For Diabetes, By Country,

2022–2030 (Usd Million)

Table 119 Asia Pacific: Autoinjector Devices Market For Diabetes, By Country, 2022–2030 (Usd Million)

Table 120 Latin America: Autoinjector Devices Market For Diabetes, By Country, 2022–2030 (Usd Million)

Table 121 Middle East & Africa: Autoinjector Devices Market For Diabetes,

By Region, 2022–2030 (Usd Million)

Table 122 Autoinjector Finished Formulations Market For Diabetes, By Region, 2022–2030 (Usd Million)

Table 123 North America: Autoinjector Finished Formulations Market For Diabetes, By Country, 2022–2030 (Usd Million)

Table 124 Europe: Autoinjector Finished Formulations Market For Diabetes,

By Country, 2022–2030 (Usd Million)

Table 125 Asia Pacific: Autoinjector Finished Formulations Market For Diabetes, By Country, 2022–2030 (Usd Million)

Table 126 Latin America: Autoinjector Finished Formulations Market For Diabetes, By Country, 2022–2030 (Usd Million)

Table 127 Middle East & Africa: Autoinjector Finished Formulations Market For Diabetes, By Region, 2022–2030 (Usd Million)

Table 128 Autoinjector Devices Market For Multiple Sclerosis, By Region,

2022–2030 (Usd Million)

Table 129 Autoinjector Devices Market For Multiple Sclerosis, By Region,

2022–2030 (Million Units)

Table 130 North America: Autoinjector Devices Market For Multiple Sclerosis,

By Country, 2022–2030 (Usd Million)

Table 131 Europe: Autoinjector Devices Market For Multiple Sclerosis,

By Country, 2022–2030 (Usd Million)

Table 132 Asia Pacific: Autoinjector Devices Market For Multiple Sclerosis,

By Country, 2022–2030 (Usd Million)

Table 133 Latin America: Autoinjector Devices Market For Multiple Sclerosis,

By Country, 2022–2030 (Usd Million)

Table 134 Middle East & Africa: Autoinjector Devices Market For Multiple Sclerosis, By Region, 2022–2030 (Usd Million)

Table 135 Autoinjector Finished Formulations Market For Multiple Sclerosis,

By Region, 2022–2030 (Usd Million)

Table 136 North America: Autoinjector Finished Formulations Market For Multiple Sclerosis, By Country, 2022–2030 (Usd Million)

Table 137 Europe: Autoinjector Finished Formulations Market For Multiple Sclerosis, By Country, 2022–2030 (Usd Million)

Table 138 Asia Pacific: Autoinjector Finished Formulations Market For Multiple Sclerosis, By Country, 2022–2030 (Usd Million)

Table 139 Latin America: Autoinjector Finished Formulations Market For Multiple Sclerosis, By Country, 2022–2030 (Usd Million)

Table 140 Middle East & Africa: Autoinjector Finished Formulations Market For Multiple Sclerosis, By Region, 2022–2030 (Usd Million)

Table 141 Autoinjector Devices Market For Anaphylaxis, By Region,

2022–2030 (Usd Million)

Table 142 Autoinjector Devices Market For Anaphylaxis, By Region,

2022–2030 (Million Units)

Table 143 North America: Autoinjector Devices Market For Anaphylaxis,

By Country, 2022–2030 (Usd Million)

Table 144 Europe: Autoinjector Devices Market For Anaphylaxis, By Country, 2022–2030 (Usd Million)

Table 145 Asia Pacific: Autoinjector Devices Market For Anaphylaxis, By Country, 2022–2030 (Usd Million)

Table 146 Latin America: Autoinjector Devices Market For Anaphylaxis,

By Country, 2022–2030 (Usd Million)

Table 147 Middle East & Africa: Autoinjector Devices Market For Anaphylaxis,

By Region, 2022–2030 (Usd Million)

Table 148 Autoinjector Finished Formulations Market For Anaphylaxis,

By Region, 2022–2030 (Usd Million)

Table 149 North America: Autoinjector Finished Formulations Market For Anaphylaxis, By Country, 2022–2030 (Usd Million)

Table 150 Europe: Autoinjector Finished Formulations Market For Anaphylaxis, By Country, 2022–2030 (Usd Million)

Table 151 Asia Pacific: Autoinjector Finished Formulations Market For Anaphylaxis, By Country, 2022–2030 (Usd Million)

Table 152 Latin America: Autoinjector Finished Formulations Market For Anaphylaxis, By Country, 2022–2030 (Usd Million)

Table 153 Middle East & Africa: Autoinjector Finished Formulations Market For Anaphylaxis, By Region, 2022–2030 (Usd Million)

Table 154 Autoinjector Devices Market For Obesity, By Region,

2022–2030 (Usd Million)

Table 155 Autoinjector Devices Market For Obesity, By Region,

2022–2030 (Million Units)

Table 156 North America: Autoinjector Devices Market For Obesity, By Country, 2022–2030 (Usd Million)

Table 157 Europe: Autoinjector Devices Market For Obesity, By Country,

2022–2030 (Usd Million)

Table 158 Asia Pacific: Autoinjector Devices Market For Obesity, By Country, 2022–2030 (Usd Million)

Table 159 Latin America: Autoinjector Devices Market For Obesity, By Country, 2022–2030 (Usd Million)

Table 160 Middle East & Africa: Autoinjector Devices Market For Obesity,

By Region, 2022–2030 (Usd Million)

Table 161 Autoinjector Finished Formulations Market For Obesity, By Region, 2022–2030 (Usd Million)

Table 162 North America: Autoinjector Finished Formulations Market For Obesity, By Country, 2022–2030 (Usd Million)

Table 163 Europe: Autoinjector Finished Formulations Market For Obesity,

By Country, 2022–2030 (Usd Million)

Table 164 Asia Pacific: Autoinjector Finished Formulations Market For Obesity,

By Country, 2022–2030 (Usd Million)

Table 165 Latin America: Autoinjector Finished Formulations Market For Obesity, By Country, 2022–2030 (Usd Million)

Table 166 Middle East & Africa: Autoinjector Finished Formulations Market For Obesity, By Region, 2022–2030 (Usd Million)

Table 167 Autoinjector Devices Market For Other Therapy Areas, By Region, 2022–2030 (Usd Million)

Table 168 Autoinjector Devices Market For Other Therapy Areas, By Region, 2022–2030 (Million Units)

Table 169 North America: Autoinjector Devices Market For Other Therapy Areas, By Country, 2022–2030 (Usd Million)

Table 170 Europe: Autoinjector Devices Market For Other Therapy Areas, By Country, 2022–2030 (Usd Million)

Table 171 Asia Pacific: Autoinjector Devices Market For Other Therapy Areas,

By Country, 2022–2030 (Usd Million)

Table 172 Latin America: Autoinjector Devices Market For Other Therapy Areas, By Country, 2022–2030 (Usd Million)

Table 173 Middle East & Africa: Autoinjector Devices Market For Other Therapy Areas, By Region, 2022–2030 (Usd Million)

Table 174 Autoinjector Finished Formulations Market For Other Therapy Areas, By Region, 2022–2030 (Usd Million)

Table 175 North America: Autoinjector Finished Formulations Market For Other Therapy Areas, By Country, 2022–2030 (Usd Million)

Table 176 Europe: Autoinjector Finished Formulations Market For Other Therapy Areas, By Country, 2022–2030 (Usd Million)

Table 177 Asia Pacific: Autoinjector Finished Formulations Market For Other Therapy Areas, By Country, 2022–2030 (Usd Million)

Table 178 Latin America: Autoinjector Finished Formulations Market For Other Therapy Areas, By Country, 2022–2030 (Usd Million)

Table 179 Middle East & Africa: Autoinjector Finished Formulations Market For Other Therapy Areas, By Region, 2022–2030 (Usd Million)

Table 180 Autoinjector Devices Market, By Volume, 2022–2030 (Usd Million)

Table 181 Autoinjector Devices Market, By Volume, 2022–2030 (Million Units)

Table 182 Up To 3ml Volume Autoinjector Devices Market, By Region,

2022–2030 (Usd Million)

Table 183 Up To 3ml Volume Autoinjector Devices Market, By Region,

2022–2030 (Million Units)

Table 184 Above 3ml Volume Autoinjector Devices Market, By Region,

2022–2030 (Usd Million)

Table 185 Above 3ml Volume Autoinjector Devices Market, By Region,

2022–2030 (Million Units)

Table 186 Autoinjector Devices Market, By End User, 2022–2030 (Usd Million)

Table 187 Autoinjector Devices Market For Home Care Settings, By Region,

2022–2030 (Usd Million)

Table 188 North America: Autoinjector Devices Market For Home Care Settings, By Country, 2022–2030 (Usd Million)

Table 189 Europe: Autoinjector Devices Market For Home Care Settings,

By Country, 2022–2030 (Usd Million)

Table 190 Asia Pacific: Autoinjector Devices Market For Home Care Settings,

By Country, 2022–2030 (Usd Million)

Table 191 Latin America: Autoinjector Devices Market For Home Care Settings,

By Country, 2022–2030 (Usd Million)

Table 192 Middle East & Africa: Autoinjector Devices Market For Home Care Settings, By Region, 2022–2030 (Usd Million)

Table 193 Autoinjector Devices Market For Hospitals & Clinics, By Region,

2022–2030 (Usd Million)

Table 194 North America: Autoinjector Devices Market For Hospitals & Clinics,

By Country, 2022–2030 (Usd Million)

Table 195 Europe: Autoinjector Devices Market For Hospitals & Clinics,

By Country, 2022–2030 (Usd Million)

Table 196 Asia Pacific: Autoinjector Devices Market For Hospitals & Clinics,

By Country, 2022–2030 (Usd Million)

Table 197 Latin America: Autoinjector Devices Market For Hospitals & Clinics,

By Country, 2022–2030 (Usd Million)

Table 198 Middle East & Africa: Autoinjector Devices Market For Hospitals & Clinics, By Region, 2022–2030 (Usd Million)

Table 199 Autoinjector Devices Market For Ambulatory Care Settings, By Region, 2022–2030 (Usd Million)

Table 200 North America: Autoinjector Devices Market For Ambulatory Care Settings, By Country, 2022–2030 (Usd Million)

Table 201 Europe: Autoinjector Devices Market For Ambulatory Care Settings,

By Country, 2022–2030 (Usd Million)

Table 202 Asia Pacific: Autoinjector Devices Market For Ambulatory Care Settings, By Country, 2022–2030 (Usd Million)

Table 203 Latin America: Autoinjector Devices Market For Ambulatory Care Settings, By Country, 2022–2030 (Usd Million)

Table 204 Middle East & Africa: Autoinjector Devices Market For Ambulatory Care Settings, By Region, 2022–2030 (Usd Million)

Table 205 Autoinjector Devices Market, By Region, 2022–2030 (Usd Million)

Table 206 Autoinjector Finished Formulations Market, By Region,

2022–2030 (Usd Million)

Table 207 North America: Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 208 North America: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 209 North America: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 210 North America: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 211 North America: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 212 North America: Autoinjector Devices Market, By Volume,

2022–2030 (Usd Million)

Table 213 North America: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 214 North America: Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 215 North America: Autoinjector Finished Formulations Market, By Usage, 2022–2030 (Usd Million)

Table 216 North America: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 217 North America: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 218 North America: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 219 North America: Autoinjector Finished Formulations Market, By Volume, 2022–2030 (Usd Million)

Table 220 North America: Autoinjector Finished Formulations Market,

By End User, 2022–2030 (Usd Million)

Table 221 Autoinjectors Approved By Us Fda, 2018–2024

Table 222 Us: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 223 Us: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 224 Us: Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 225 Us: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 226 Us: Autoinjector Devices Market, By End User, 2022–2030 (Usd Million)

Table 227 Us: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 228 Us: Autoinjector Finished Formulations Market, By Technology,

2022–2030 (Usd Million)

Table 229 Us: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 230 Us: Autoinjector Finished Formulations Market, By Therapy Area,

2022–2030 (Usd Million)

Table 231 Us: Autoinjector Finished Formulations Market, By End User,

2022–2030 (Usd Million)

Table 232 Canada: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 233 Canada: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 234 Canada: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 235 Canada: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 236 Canada: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 237 Canada: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 238 Canada: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 239 Canada: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 240 Canada: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 241 Canada: Autoinjector Finished Formulations Market, By End User, 2022–2030 (Usd Million)

Table 242 Europe: Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 243 Europe: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 244 Europe: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 245 Europe: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 246 Europe: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 247 Europe: Autoinjector Devices Market, By Volume,

2022–2030 (Usd Million)

Table 248 Europe: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 249 Europe: Autoinjector Finished Formulations Market, By Country,

2022–2030 (Usd Million)

Table 250 Europe: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 251 Europe: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 252 Europe: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 253 Europe: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 254 Europe: Autoinjector Finished Formulations Market, By Volume,

2022–2030 (Usd Million)

Table 255 Europe: Autoinjector Finished Formulations Market, By End User, 2022–2030 (Usd Million)

Table 256 Germany: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 257 Germany: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 258 Germany: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 259 Germany: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 260 Germany: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 261 Germany: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 262 Germany: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 263 Germany: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 264 Germany: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 265 Germany: Autoinjector Finished Formulations Market, By End User, 2022–2030 (Usd Million)

Table 266 Uk: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 267 Uk: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 268 Uk: Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 269 Uk: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 270 Uk: Autoinjector Devices Market, By End User, 2022–2030 (Usd Million)

Table 271 Uk: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 272 Uk: Autoinjector Finished Formulations Market, By Technology,

2022–2030 (Usd Million)

Table 273 Uk: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 274 Uk: Autoinjector Finished Formulations Market, By Therapy Area,

2022–2030 (Usd Million)

Table 275 Uk: Autoinjector Finished Formulations Market, By End User,

2022–2030 (Usd Million)

Table 276 France: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 277 France: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 278 France: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 279 France: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 280 France: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 281 France: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 282 France: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 283 France: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 284 France: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 285 France: Autoinjector Finished Formulations Market, By End User, 2022–2030 (Usd Million)

Table 286 Italy: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 287 Italy: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 288 Italy: Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 289 Italy: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 290 Italy: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 291 Italy: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 292 Italy: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 293 Italy: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2 030 (Usd Million)

Table 294 Italy: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 295 Italy: Autoinjector Finished Formulations Market, By End User,

2022–2030 (Usd Million)

Table 296 Spain: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 297 Spain: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 298 Spain: Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 299 Spain: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 300 Spain: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 301 Spain: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 302 Spain: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 303 Spain: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 304 Spain: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 305 Spain: Autoinjector Finished Formulations Market, By End User,

2022–2030 (Usd Million)

Table 306 Rest Of Europe: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 307 Rest Of Europe: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 308 Rest Of Europe: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 309 Rest Of Europe: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 310 Rest Of Europe: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 311 Rest Of Europe: Autoinjector Finished Formulations Market, By Usage, 2022–2030 (Usd Million)

Table 312 Rest Of Europe: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 313 Rest Of Europe: Autoinjector Finished Formulations Market,

By Route Of Administration, 2022–2030 (Usd Million)

Table 314 Rest Of Europe: Autoinjector Finished Formulations Market,

By Therapy Area, 2022–2030 (Usd Million)

Table 315 Rest Of Europe: Autoinjector Finished Formulations Market,

By End User, 2022–2030 (Usd Million)

Table 316 Asia Pacific: Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 317 Asia Pacific: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 318 Asia Pacific: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 319 Asia Pacific: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 320 Asia Pacific: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 321 Asia Pacific: Autoinjector Devices Market, By Volume,

2022–2030 (Usd Million)

Table 322 Asia Pacific: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 323 Asia Pacific: Autoinjector Finished Formulations Market, By Country, 2022–2030 (Usd Million)

Table 324 Asia Pacific: Autoinjector Finished Formulations Market, By Usage, 2022–2030 (Usd Million)

Table 325 Asia Pacific: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 326 Asia Pacific: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 327 Asia Pacific: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 328 Asia Pacific: Autoinjector Finished Formulations Market, By Volume, 2022–2030 (Usd Million)

Table 329 Asia Pacific: Autoinjector Finished Formulations Market, By End User, 2022–2030 (Usd Million)

Table 330 Japan: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 331 Japan: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 332 Japan: Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 333 Japan: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 334 Japan: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 335 Japan: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 336 Japan: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 337 Japan: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 338 Japan: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 339 Japan: Autoinjector Finished Formulations Market, By End User,

2022–2030 (Usd Million)

Table 340 China: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 341 China: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 342 China: Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 343 China: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 344 China: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 345 China: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 346 China: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 347 China: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 348 China: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 349 China: Autoinjector Finished Formulations Market, By End User,

2022–2030 (Usd Million)

Table 350 India: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 351 India: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 352 India: Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 353 India: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 354 India: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 355 India: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 356 India: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 357 India: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 358 India: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 359 India: Autoinjector Finished Formulations Market, By End User,

2022–2030 (Usd Million)

Table 360 South Korea: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 361 South Korea: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 362 South Korea: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 363 South Korea: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 364 South Korea: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 365 South Korea: Autoinjector Finished Formulations Market, By Usage, 2022–2030 (Usd Million)

Table 366 South Korea: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 367 South Korea: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 368 South Korea: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 369 South Korea: Autoinjector Finished Formulations Market, By End User, 2022–2030 (Usd Million)

Table 370 Rest Of Asia Pacific: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 371 Rest Of Asia Pacific: Autoinjector Devices Market, By Technology, 2022–2030 (Usd Million)

Table 372 Rest Of Asia Pacific: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 373 Rest Of Asia Pacific: Autoinjector Devices Market, By Therapy Area, 2022–2030 (Usd Million)

Table 374 Rest Of Asia Pacific: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 375 Rest Of Asia Pacific: Autoinjector Finished Formulations Market,

By Usage, 2022–2030 (Usd Million)

Table 376 Rest Of Asia Pacific: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 377 Rest Of Asia Pacific: Autoinjector Finished Formulations Market,

By Route Of Administration, 2022–2030 (Usd Million)

Table 378 Rest Of Asia Pacific: Autoinjector Finished Formulations Market,

By Therapy Area, 2022–2030 (Usd Million)

Table 379 Rest Of Asia Pacific: Autoinjector Finished Formulations Market,

By End User, 2022–2030 (Usd Million)

Table 380 Latin America: Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 381 Latin America: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 382 Latin America: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 383 Latin America: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 384 Latin America: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 385 Latin America: Autoinjector Devices Market, By Volume,

2022–2030 (Usd Million)

Table 386 Latin America: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 387 Latin America: Autoinjector Finished Formulations Market, By Country, 2022–2030 (Usd Million)

Table 388 Latin America: Autoinjector Finished Formulations Market, By Usage, 2022–2030 (Usd Million)

Table 389 Latin America: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 390 Latin America: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 391 Latin America: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 392 Latin America: Autoinjector Finished Formulations Market, By Volume, 2022–2030 (Usd Million)

Table 393 Latin America: Autoinjector Finished Formulations Market,

By End User, 2022–2030 (Usd Million)

Table 394 Brazil: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 395 Brazil: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 396 Brazil: Autoinjector Devices Market, By Route Of Administration,

2022–2030 (Usd Million)

Table 397 Brazil: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 398 Brazil: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 399 Brazil: Autoinjector Finished Formulations Market, By Usage,

2022–2030 (Usd Million)

Table 400 Brazil: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 401 Brazil: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 402 Brazil: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 403 Brazil: Autoinjector Finished Formulations Market, By End User,

2022–2030 (Usd Million)

Table 404 Rest Of Latin America: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 405 Rest Of Latin America: Autoinjector Devices Market, By Technology, 2022–2030 (Usd Million)

Table 406 Rest Of Latin America: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 407 Rest Of Latin America: Autoinjector Devices Market, By Therapy Area, 2022–2030 (Usd Million)

Table 408 Rest Of Latin America: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 409 Rest Of Latin America: Autoinjector Finished Formulations Market,

By Usage, 2022–2030 (Usd Million)

Table 410 Rest Of Latin America: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 411 Rest Of Latin America: Autoinjector Finished Formulations Market,

By Route Of Administration, 2022–2030 (Usd Million)

Table 412 Rest Of Latin America: Autoinjector Finished Formulations Market,

By Therapy Area, 2022–2030 (Usd Million)

Table 413 Rest Of Latin America: Autoinjector Finished Formulations Market,

By End User, 2022–2030 (Usd Million)

Table 414 Middle East & Africa: Autoinjector Devices Market, By Country,

2022–2030 (Usd Million)

Table 415 Middle East & Africa: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 416 Middle East & Africa: Autoinjector Devices Market, By Technology, 2022–2030 (Usd Million)

Table 417 Middle East & Africa: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 418 Middle East & Africa: Autoinjector Devices Market, By Therapy Area, 2022–2030 (Usd Million)

Table 419 Middle East & Africa: Autoinjector Devices Market, By Volume,

2022–2030 (Usd Million)

Table 420 Middle East & Africa: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 421 Middle East & Africa: Autoinjector Finished Formulations Market,

By Country, 2022–2030 (Usd Million)

Table 422 Middle East & Africa: Autoinjector Finished Formulations Market,

By Usage, 2022–2030 (Usd Million)

Table 423 Middle East & Africa: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 424 Middle East & Africa: Autoinjector Finished Formulations Market,

By Route Of Administration, 2022–2030 (Usd Million)

Table 425 Middle East & Africa: Autoinjector Finished Formulations Market,

By Therapy Area, 2022–2030 (Usd Million)

Table 426 Middle East & Africa: Autoinjector Finished Formulations Market,

By Volume, 2022–2030 (Usd Million)

Table 427 Middle East & Africa: Autoinjector Finished Formulations Market,

By End User, 2022–2030 (Usd Million)

Table 428 Gcc Countries: Autoinjector Devices Market, By Usage,

2022–2030 (Usd Million)

Table 429 Gcc Countries: Autoinjector Devices Market, By Technology,

2022–2030 (Usd Million)

Table 430 Gcc Countries: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 431 Gcc Countries: Autoinjector Devices Market, By Therapy Area,

2022–2030 (Usd Million)

Table 432 Gcc Countries: Autoinjector Devices Market, By End User,

2022–2030 (Usd Million)

Table 433 Gcc Countries: Autoinjector Finished Formulations Market, By Usage, 2022–2030 (Usd Million)

Table 434 Gcc Countries: Autoinjector Finished Formulations Market,

By Technology, 2022–2030 (Usd Million)

Table 435 Gcc Countries: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 436 Gcc Countries: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 437 Gcc Countries: Autoinjector Finished Formulations Market, By End User, 2022–2030 (Usd Million)

Table 438 Rest Of Middle East & Africa: Autoinjector Devices Market, By Usage, 2022–2030 (Usd Million)

Table 439 Rest Of Middle East & Africa: Autoinjector Devices Market,

By Technology, 2022–2030 (Usd Million)

Table 440 Rest Of Middle East & Africa: Autoinjector Devices Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 441 Rest Of Middle East & Africa: Autoinjector Devices Market, By Therapy Area, 2022–2030 (Usd Million)

Table 442 Rest Of Middle East & Africa: Autoinjector Devices Market,

By End User, 2022–2030 (Usd Million)

Table 443 Rest Of Middle East & Africa: Autoinjector Finished Formulations Market, By Usage, 2022–2030 (Usd Million)

Table 444 Rest Of Middle East & Africa: Autoinjector Finished Formulations Market, By Technology, 2022–2030 (Usd Million)

Table 445 Rest Of Middle East & Africa: Autoinjector Finished Formulations Market, By Route Of Administration, 2022–2030 (Usd Million)

Table 446 Rest Of Middle East & Africa: Autoinjector Finished Formulations Market, By Therapy Area, 2022–2030 (Usd Million)

Table 447 Rest Of Middle East & Africa: Autoinjector Finished Formulations Market, By End User, 2022–2030 (Usd Million)

Table 448 Overview Of Strategies Deployed By Key Autoinjector Device Manufacturing Companies

Table 449 Autoinjector Devices Market: Degree Of Competition

Table 450 Autoinjector Finished Formulations Market: Degree Of Competition

Table 451 Autoinjector Devices Market: Region Footprint

Table 452 Autoinjector Finished Formulations Market: Region Footprint

Table 453 Autoinjector Devices Market: Usage Footprint

Table 454 Autoinjector Finished Formulations Market: Usage Footprint

Table 455 Autoinjector Devices Market: Volume Footprint

Table 456 Autoinjector Devices Market: Route Of Administration Footprint

Table 457 Autoinjector Finished Formulations Market: Route Of

Administration Footprint

Table 458 Autoinjectors Market: Detailed List Of Key Startups/Smes

Table 459 Autoinjectors Market: Competitive Benchmarking Of

Key Startup/Sme Players

Table 460 Autoinjectors Market: Product Launches And Approvals,

January 2021–july 2024

Table 461 Autoinjectors Market: Deals, January 2021–july 2024

Table 462 Autoinjectors Market: Expansions, January 2021–july 2024

Table 463 Autoinjectors Market: Devices For Large-volume Formulations

Table 464 Autoinjectors Market: Devices For Highly Viscous Formulations

Table 465 Formulation And Device Technologies Enabling Subcutaneous Delivery Of High-dose Biologics

Table 466 Shl Medical Ag: Company Overview

Table 467 Shl Medical Ag: Products Offered

Table 468 Shl Medical Ag: Product Launches, January 2021–july 2024

Table 469 Shl Medical Ag: Deals, January 2021–july 2024

Table 470 Shl Medical Ag: Expansions, January 2021–july 2024

Table 471 Ypsomed Ag: Company Overview

Table 472 Ypsomed Ag: Products Offered

Table 473 Ypsomed Ag: Product Launches, January 2021–july 2024

Table 474 Ypsomed Ag: Deals, January 2021–july 2024

Table 475 Ypsomed Ag: Expansions, January 2021–july 2024

Table 476 Becton, Dickinson And Company (Bd): Company Overview

Table 477 Becton, Dickinson And Company (Bd): Products Offered

Table 478 Becton, Dickinson And Company (Bd): Deals, January 2021–july 2024

Table 479 Becton, Dickinson And Company (Bd): Other Developments,

January 2021–july 2024

Table 480 Recipharm Ab: Company Overview

Table 481 Recipharm Ab: Products Offered

Table 482 West Pharmaceutical Services, Inc.: Company Overview

Table 483 West Pharmaceutical Services, Inc.: Products Offered

Table 484 West Pharmaceutical Services, Inc.: Expansions,

January 2021–july 2024

Table 485 Phillips-medisize: Company Overview

Table 486 Phillips-medisize: Products Offered

Table 487 Phillips-medisize: Product Launches, January 2021–july 2024

Table 488 Halozyme, Inc.: Company Overview

Table 489 Halozyme, Inc.: Products Offered

Table 490 Owen Mumford Ltd.: Company Overview

Table 491 Owen Mumford Ltd.: Products Offered

Table 492 Owen Mumford Ltd.: Product Launches, January 2021–july 2024

Table 493 Owen Mumford Ltd.: Deals, January 2021–july 2024

Table 494 Owen Mumford Ltd.: Expansions, January 2021–july 2024

Table 495 Abbvie Inc.: Company Overview

Table 496 Abbvie Inc.: Products Offered

Table 497 Abbvie Inc: Product Launches And Approvals, January 2021–july 2024

Table 498 Eli Lilly And Company: Company Overview

Table 499 Eli Lilly And Company: Products Offered

Table 500 Eli Lilly And Company: Product Approvals, January 2021–july 2024

Table 501 Eli Lilly And Company: Deals, January 2021–july 2024

Table 502 Amgen Inc.: Company Overview

Table 503 Amgen Inc.: Products Offered

Table 504 Amgen Inc.: Product Launches, January 2021–july 2024

Table 505 Novo Nordisk A/S: Company Overview

Table 506 Novo Nordisk A/S: Products Offered

Table 507 Novo Nordisk A/S: Product Approvals, January 2021–july 2024

Table 508 Novo Nordisk A/S: Deals, January 2021–july 2024

Table 509 Novo Nordisk A/S: Expansions, January 2021–july 2024

Table 510 Novo Nordisk A/S: Other Developments, January 2021–july 2024

Table 511 Johnson & Johnson Services, Inc.: Company Overview

Table 512 Johnson & Johnson Services, Inc.: Products Offered

Table 513 Sanofi: Company Overview

Table 514 Sanofi: Products Offered

Table 515 Gsk Plc: Company Overview

Table 516 Gsk Plc: Products Offered

Table 517 Gsk Plc: Product Approvals, January 2021–july 2024

Table 518 Gerresheimer Ag: Company Overview

Table 519 Haselmeier: Company Overview

Table 520 Oval Medical Technologies Ltd.: Company Overview

Table 521 Kaleo, Inc.: Company Overview

Table 522 Solteam Incorporation Co., Ltd.: Company Overview

Table 523 Elcam Drug Delivery Devices: Company Overview

Table 524 Crossject: Company Overview

Table 525 Jabil Inc.: Company Overview

Table 526 Congruence Medical Solutions Llc: Company Overview

Table 527 Midas Pharma Gmbh: Company Overview

Figures List

Figure 1 Autoinjectors Market: Segments Considered

Figure 2 Autoinjectors Market: Years Considered

Figure 3 Autoinjectors Market: Research Design

Figure 4 Autoinjectors Market: Breakdown Of Primaries

(Supply- And Demand-side Participants)

Figure 5 Market Size Estimation: Supply-side Analysis

Figure 6 Market Size Estimation For Autoinjector Devices:

Revenue Share Analysis

Figure 7 Illustrative Example Of Ypsomed Ag: Revenue Share Analysis (2023)

Figure 8 Market Size Estimation: Supply-side Analysis

Figure 9 Market Size Estimation For Autoinjector Finished Formulations: Revenue Share Analysis

Figure 10 Illustrative Example Of Abbvie Inc.: Revenue Share Analysis (2023)

Figure 11 Autoinjectors Market: Market Validation From Primary Experts

Figure 12 Market Size Estimation Methodology: Top-down Approach

Figure 13 Autoinjector Devices Market Size Estimation

Figure 14 Autoinjector Devices Market: Cagr Projections (2024–2030)

Figure 15 Autoinjector Finished Formulations Market: Cagr Projections

(2024–2030)

Figure 16 Data Triangulation Methodology

Figure 17 Autoinjector Devices Market, By Usage, 2024 Vs. 2030 (Usd Million)

Figure 18 Autoinjector Devices Market, By Usage, 2024 Vs. 2030 (Million Units)

Figure 19 Autoinjector Finished Formulations Market, By Usage,

2024 Vs. 2030 (Usd Billion)

Figure 20 Autoinjector Devices Market, By Route Of Administration,

2024 Vs. 2030 (Usd Million)

Figure 21 Autoinjector Finished Formulations Market, By Route Of Administration, 2024 Vs. 2030 (Usd Billion)

Figure 22 Autoinjector Devices Market, By End User, 2024 Vs. 2030 (Usd Million)

Figure 23 Autoinjector Finished Formulations Market, By End User,

2024 Vs. 2030 (Usd Billion)

Figure 24 Autoinjector Devices Market: Regional Snapshot

Figure 25 Autoinjector Finished Formulations Market: Regional Snapshot

Figure 26 Increasing Regulatory Approvals For Finished Formulation Drugs To Propel Market Growth

Figure 27 Us And Disposable Autoinjectors Dominated Market In 2023

Figure 28 Us And Subcutaneous Route Of Administration Commanded Larger Market Share In 2023

Figure 29 Rheumatoid Arthritis To Dominate Market During Forecast Period

Figure 30 Manual Autoinjectors Accounted For Largest Market Share In 2023

Figure 31 Asia Pacific To Register Highest Growth Rate From 2024 To 2030

Figure 32 Asia Pacific To Command Highest Cagr During Study Period

Figure 33 Autoinjectors Market: Drivers, Restraints, Opportunities, And Challenges

Figure 34 Revenue Shift And Pockets For Autoinjector Providers

Figure 35 Autoinjector Devices Market: Value Chain Analysis

Figure 36 Autoinjector Finished Formulations Market: Value Chain Analysis

Figure 37 Autoinjectors Market: Supply Chain Analysis

Figure 38 Autoinjectors Market: Ecosystem Map

Figure 39 Autoinjectors Market: Porter’s Five Forces Analysis

Figure 40 Total Number Of Patents Granted, 2014–2023

Figure 41 Top Ten Players With Highest Number Of Patent

Applications, 2014–2024

Figure 42 Regional Analysis Of Patents Granted, 2014–2024

Figure 43 Average Selling Price Trend, By Product Type (2021–2023)

Figure 44 Average Selling Price Trend, By Usage (2023)

Figure 45 Key Stakeholders In Buying Process For Pharmaceutical Companies (Autoinjector Devices)

Figure 46 Key Stakeholders In Buying Process For Hospitals

(Autoinjector Finished Formulations)

Figure 47 Key Buying Criteria For Autoinjector Devices Among End Users

Figure 48 Key Buying Criteria For Autoinjector Finished Formulations

Among End Users

Figure 49 North America: Autoinjector Devices Market Snapshot (2023)

Figure 50 North America: Autoinjector Finished Formulations Market Snapshot (2023)

Figure 51 Europe: Autoinjector Devices Market Snapshot

Figure 52 Europe: Autoinjector Finished Formulations Market Snapshot

Figure 53 Revenue Analysis Of Key Players In Autoinjector Devices Market

(2021–2023)

Figure 54 Revenue Analysis Of Key Players In Autoinjector Finished Formulations Market (2021–2023)

Figure 55 Market Share Analysis Of Key Players In Autoinjector Devices Market (2023)

Figure 56 Market Share Analysis Of Key Players In Autoinjector Finished Formulations Market (2023)

Figure 57 Autoinjector Devices Market: Company Evaluation Matrix

(Key Players), 2023

Figure 58 Autoinjector Finished Formulations Market: Company Evaluation Matrix (Key Players), 2023

Figure 59 Autoinjector Devices Market: Company Footprint

Figure 60 Autoinjector Finished Formulations Market: Company Footprint

Figure 61 Autoinjector Devices Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 62 Ev/Ebitda Of Key Vendors

Figure 63 Year-to-date (Ytd) Price Total Return And 5-year Stock

Beta Of Key Vendors

Figure 64 Autoinjector Devices Market: Brand/Product Comparative Analysis

Figure 65 Ypsomed Ag: Company Snapshot (2023)

Figure 66 Becton, Dickinson And Company (Bd): Company Snapshot (2023)

Figure 67 West Pharmaceutical Services, Inc.: Company Snapshot (2023)

Figure 68 Halozyme, Inc.: Company Snapshot (2023)

Figure 69 Abbvie Inc.: Company Snapshot (2023)

Figure 70 Eli Lilly And Company: Company Snapshot (2023)

Figure 71 Amgen Inc.: Company Snapshot (2023)

Figure 72 Novo Nordisk A/S: Company Snapshot (2023)

Figure 73 Johnson & Johnson Services, Inc.: Company Snapshot (2023)

Figure 74 Sanofi: Company Snapshot (2023)

Figure 75 Gsk Plc: Company Snapshot (2023)